ZOETIS INC. (ZTS) is a publicly traded Healthcare sector company. As of May 20, 2026, ZTS trades at $79.80 with a market cap of $32.58B and a P/E ratio of 13.29. ZTS moved +0.87% today. Year to date, ZTS is -38.39%; over the trailing twelve months it is -51.29%. Its 52-week range spans $72.38 to $197.51. Analyst consensus is buy with an average price target of $129.29. Rallies surfaces ZTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded ZTS stock?
Recent politician trading activity in ZTS includes disclosures from Gilbert Cisneros, Markwayne Mullin, Ro Khanna, Rick Larsen, and Rob Bresnahan. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
ZTS Key Metrics
Key financial metrics for ZTS
Metric
Value
Price
$79.80
Market Cap
$32.58B
P/E Ratio
13.29
EPS
$6.04
Dividend Yield
0.53%
52-Week High
$197.51
52-Week Low
$72.38
Volume
5.99M
Avg Volume
0
Revenue (TTM)
$9.51B
Net Income
$2.64B
Gross Margin
71.76%
Congressional Trades in ZTS
Gilbert Cisneros purchase ZTS on Feb 10, 2026 (amount: $15.00K).
Markwayne Mullin sale ZTS on Nov 10, 2025 (amount: $50.00K) for Joint.
Ro Khanna purchase ZTS on Oct 27, 2025 (amount: $15.00K).
Rick Larsen sale ZTS on Oct 6, 2025 (amount: $15.00K).
Rob Bresnahan purchase ZTS on May 15, 2025 (amount: $15.00K).
Recent politician trading activity in ZTS includes disclosures from Gilbert Cisneros, Markwayne Mullin, Ro Khanna, Rick Larsen, and Rob Bresnahan. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in ZTS?
Yes. Rallies tracks politician and congressional stock disclosures for ZTS, including reported purchases, sales, dates, owners, and trade amounts when available.
Is ZTS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ZTS. It does not provide personalized investment advice.